Med Cause -

Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according to a study presented at the annual meeting of the American Association of Clinical Endocrinology, held from May 9 to 11 in New Orleans.

Paramesh Shamanna, M.D., from the Bangalore Diabetes Center in India, and colleagues evaluated the effectiveness of the digital twin (DT) technology to improve hemoglobin A1C (HbA1c) and 10-year ASCVD risk.
The analysis included 208 individuals assigned to the DT intervention (a mobile app that uses AI and Internet of Things to integrate multidimensional data to give precision nutrition and health recommendations) and 81 assigned to standard of care.
The researchers found that overall, 72.5 percent sustained diabetes remission in one year. There was a significantly larger difference in the change in HbA1c in the DT group versus standard of care (−3 versus −0.2). Further, the DT group had a marked decrease in the ASCVD risk profile at 360 days, with 76.6 percent of participants categorized as low-risk versus 49.1 percent at baseline.
By comparison, the standard-care group showed a marginal increase in the low-risk category from 43.2 to 45.7 percent. In the DT group, reductions in the high-risk category were more pronounced, while the standard-care group remained unchanged. There was a significant positive correlation between the change in ASCVD risk in the DT group versus the standard-care group (−4.3 versus −0.97).
“Digital twin technology significantly enhanced HbA1c reduction and reduced 10-year ASCVD risk in type 2 diabetes mellitus patients, outperforming standard care and demonstrating its potential in precision diabetes management,” the authors write.

More information:
Paramesh Shamanna et al, #1706999 The Impact of Digital Twin Technology on HbA1c Reduction and ASCVD Risk in Participants Enrolled for Type 2 Diabetes Remission: Outcomes of RCCT At 1 Year, Endocrine Practice (2024). DOI: 10.1016/j.eprac.2024.03.278
More Information

Copyright © 2024 HealthDay. All rights reserved.

AI-informed health app aids diabetes outcomes (2024, May 16)
retrieved 19 May 2024

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Share this article
Shareable URL
Prev Post
Next Post
Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
SPINA-DI is a novel simple reliable and inexpensive marker of insulin-glucose homeostasis suitable for screening…
Credit: Unsplash/CC0 Public Domain A new study appearing in BMC Health Services Research from the Texas A&M…
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do…
Need Help?